Email ID
Sign me in automatically next time

About Us

SCRIP Intelligence is the leading source of news and strategic analysis for the global pharmaceutical industry. We filter the flood of information on the industry and apply the knowledge of our extensive network of analysts, journalists and key opinion leaders to provide our readers with timely business-critical market and competitor intelligence.

Our experienced writers and analysts are based in key geographic markets and cover all aspects of the industry – from small biotech start-ups to multinational giants, research boutiques to generic manufacturers. We focus on the whole of the drug discovery and development value chain and report on regulatory news, product approvals and rejections, and key corporate events.

In addition to our internal resources, SCRIP Intelligence reaches out to expert colleagues in other Informa businesses including Datamonitor, Citeline, Scrip Business Insights, Scrip Regulatory Affairs, Clinica and the Informa Healthcare journals. Owing to our high standing within the industry and the credibility of our writers, SCRIP Intelligence also enjoys privileged access to the industry's key thinkers and opinion leaders.


Eleanor Malone
Interim Editor

+44 207 017 6976
Eleanor has been reporting and analysing pharmaceutical news since 2000, covering a full range of topics including M&A deals, financial reporting, company strategy and business development, drug successes and failures both in the clinic and on the market, policy and regulation, polemic, controversy and industry-related foresight and overview.


Donna Young
Washington Editor

+1 301 216 2433
Donna covers all Washington biopharma-related daily news, regulatory, legislative and legal, and writes the weekly US Capitol Capsule column.
Donna has covered healthcare policies, legislation, regulations and legal news from Washington for more than a decade. She has extensive knowledge of the FDA, the NIH and other federal agencies, including the Department of Homeland Security, the US Patent & Trademark Office and the Federal Trade Commission.

Mandy Jackson
West Coast Editor

+1 619 681 4631
Mandy Jackson is the US West Coast Editor for Scrip Intelligence. Her focus is US biotech and pharma, including financial, deal making and clinical trials news. Mandy has been a business news reporter for 15 years, covering biotech and pharma companies, biotech law and commercial real estate. She is based in San Diego, California.

Back to top
SCRIP Asia team

Ian Haydock
Asia Editor

+81 042 259 1134
Ian is based in Tokyo and covers the Asian pharma markets for Scrip. He writes about a broad range of business strategy and development, policy/regulatory and R&D issues relevant to both big pharma and smaller start-up firms, and has a particular interest in regulatory convergence initiatives in Asia. Ian also provides coverage of the Australian bioventure sector, while his regular ‘Asia Beat’ column is published every two weeks and takes an analytical angle on major regional news.

Anju Ghangurde
South-East Asia Editor

+91 982 028 8667
Anju is responsible for reporting from India, a country that's often described as the pharmacy of the world. With close to a decade of previous experience in India's mainstream financial dailies, she writes extensive coverage on a broad range of issues including the generics versus brand name firms' play, pricing, the evolving regulatory and legal framework and company strategies.

Wang Fangqing
Chinese Healthcare Reporter
Wang Fangqing covers news and regulations in China, a huge, booming yet challenging market for foreign pharmaceutical companies. Previously, she has also worked with PharmAsia News and BioPharm Insight. She is based in Shanghai.
Back to top
SCRIP Europe team

Alexandra Shimmings
Managing Editor

+44 207 017 6954
Alex has 17 years' experience in writing about the pharmaceutical industry, specialising in drug development, clinical trials and data.

Sukaina Virji
News Editor

+44 203 377 3756
Sukaina has been covering the pharmaceutical and biotechnology space for Scrip for more than six years, writing business, regulatory and clinical development news and analysis. Prior to working on Scrip, Suki was editor of BioVenture View newsletter and BioPeople magazine, publications which focused exclusively on the biotechnology sector, including financial and R&D news. She has a PhD in biochemistry and molecular biology from University College London.

John Hodgson
i Editor

+44 203 377 3923
John has been a commentator and participant in biotechnology and life sciences research for over three decades as a writer and consultant. His focus has been on the use of deep data of all kinds to dispel market myths and redirect efforts in early commercial decision-making.

Francesca Bruce
Senior Reporter

+44 207 017 5397
Francesca covers a range of policy and regulatory developments in Europe, with a focus on pricing and reimbursement and market access. In her role at Scrip she has also covered key emerging markets in Latin America, concentrating on Brazil, Mexico and Argentina.

Gemma Collier

+44 203 377 3891
Gemma is a reporter on Scrip based in the UK. She covers a range of global news and analysis topics including people and appointments, clinical trial results, corporate financings, and marketing strategies including branding and social media.

Lucie Ellis
Editorial Assistant

+44 207 017 4417
Lucie is based in Scrip's UK office. She joined the team as an intern in 2012 after graduating from Sheffield Hallam University with a BA (hons) Degree in Journalism. As editorial assistant Lucie covers a range of global news including: people and appointments; corporate financings and M&A activities; R&D news; and digital/social media development in the industry.
Back to top

Dr Peter Charlish
Peter focuses on drug discovery and product development, including clinical trials, and regulatory affairs, with knowledge extending across pharma, medical devices and diagnostics.

Ian Schofield
Ian writes on a wide range of issues affecting the pharmaceutical and biotech industry, with a focus on EU regulatory, political, legal and scientific affairs. He also covers specialist areas such as advanced therapies, paediatrics, generics, orphans, counterfeits and pandemic flu.

Ashley Yeo
Ashley has a wealth experience of the medical technology and healthcare sectors, focusing on healthcare and trade policy, business and financial performance and regulatory affairs. He was editor of Clinica for nine years until April 2009. 
Back to top
Mike Ward
Global Director of Content
Mike has been writing, analysing and commenting on the life sciences industry for the past 30 years. He has focused on business models, R&D strategies and how to finance innovation, and is often called upon by the industry's key stakeholders to provide thought leadership. In 2010 he was named European Mediscience Commentator of the Year.

Phil Jarvis
Publishing Director
Phil is Publishing Director for the Scrip Group. Phil has over 12 years' experience in the world of B2B publishing covering the research-driven Crop Protection and Healthcare industries. Phil has a vision to grow the Scrip Group business through digital delivery of original, market-leading content.
Back to top

Marketing & Customer Services
Lucy Fite
Marketing Manager
Dan Frere
Retention Team Leader
New Subscriptions
+44 (0)20 7017 7572
Customer Service Team
+44 (0)20 7017 4161
Back to top

To explore the complete range of pharma news, data and analysis that our subscribers enjoy every day, click on the button below to start your free trial.

21 January 2015
Marriott Regents Park Hotel, London UK
21 January 2015
Marriott Regents Park Hotel, London, UK
03 February 2015
ETC Venues, 155 Bishopsgate
© 2014 Informa plc. All rights reserved.
This site is owned and operated by Informa plc ("Informa") whose registered office is Mortimer House, 37-41 Mortimer Street, London, W1T 3JH. Registered in England and Wales. Number 3099067. UK VAT Group: GB 365 4626 36